CC
LVTX

Cannell Capital’s LAVA Therapeutics LVTX Stock Holding History

Cannell Capital’s Portfolio LVTX Stock Details LVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,955
Closed -$29.8K – 79
2023
Q1 		$29.8K Hold
17,955
– – 0.01% 81
2022
Q4 		$62.8K Hold
17,955
– – 0.01% 64
2022
Q3 		$82K Buy
17,955
+13,897
+342% +$38.3K 0.02% 64
2022
Q2 		$12K Buy
+4,058
New +$14.1K ﹤0.01% 70

Other funds holding LVTX

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return